Beit Jala Pharmaceutical Stock: price and insider trades · Palestine
1 insider bought shares over the last 90 days, the latest by حمد جمال اسعد مصري, filed 20 Sept 2026.
Beit Jala Pharmaceutical: what insiders have been doing
This page follows insider dealings at Beit Jala Pharmaceutical as filed with PCMA / Palestine Exchange. 4 insiders have disclosed 5 filings since 15 November 2025.
Open-market activity splits into 3 purchases and 2 sales; 2 insiders sit on the buying side and 2 insiders on the selling side. The totals exclude 5 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 2 board members.
The last insider purchase was made public on 20 September 2026, 58 days ago.
Across the 51 companies tracked on its exchange, the median is 9 filings; at 5 filings, this issuer sits below that mark. Our records for Beit Jala Pharmaceutical go back to 2021, with 5 purchases and 5 sales on the open market in total.
These figures are compiled from regulatory filings published by PCMA / Palestine Exchange. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleFinancial data
· cache
T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.
- 10,000 sharesSharePEXPEX:05b786948ff8-1Canonical exit: 19 Dec 2026 (T+90)
- 132,383 sharesSharePEXPEX:94263a68bcdd-1Canonical exit: 13 Apr 2026 (T+90)
- 5,595,391 sharesSharePEXPEX:3df38d049ba7-1
- 5,727,774 sharesSharePEXPEX:4a705c462879-1Canonical exit: 23 Mar 2026 (T+90)
- 120,000 sharesSharePEXPEX:8af85a9b23aa-1
- 300 sharesSharePEXPEX:562c3fe0df68-1
- 200 sharesSharePEXPEX:dc912db26fe5-1
- 184 sharesSharePEXPEX:6cdc471b015c-1Canonical exit: 18 Jan 2026 (T+90)
- 1,000 sharesSharePEXPEX:846ad8faf986-1Canonical exit: 21 Jan 2024 (T+90)
- 10,000 sharesSharePEXPEX:3873059ff6b2-1
10 of 10 declarations
About Beit Jala Pharmaceutical
Beit Jala Pharmaceutical is a pharmaceutical company based in Beit Jala, specializing in the manufacture of medicines and health products. It operates in the XPAE market.
Written on 14 November 2026 from the filings and market data available that day. Live figures are in the blocks above.
The weekly insider digest, free
One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.